Consequently, to determine the role of non‐pathogenic variants of APP, PSEN1, and PSEN2 in AD, we comprehensively analyzed these non‐pathogenic variants between AD patients and controls in a large Chinese population via a targeted sequencing panel. The gene discussed is PSEN1; the disease is Alzheimer disease.